ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd (TAK)

15,68
0,00
(0,00%)
Geschlossen 11 Juni 10:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

Takeda Pharmaceutical Company Ltd (TAK) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
15,68
( - )
Gebot
-
Fragen
-
Volumen
-
0,00 Tagesbereich 0,00
12,99 52-Wochen-Bereich 18,895
Marktkapitalisierung
Handelsende
15,68
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 4.428.136
Ausgegebene Aktien
1.579.837.574
Dividendenrendite (LTM)
200 (4,10%)
Kurs-Gewinn-Verhältnis
42,21
Gewinn pro Aktie (EPS)
119,64
Erlöse (LTM)
4,51T
Nettogewinn (LTM)
191,76B

Über Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, onco... Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba Fiber, Recombinate, Hemofil, Immunate, Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-licensing agreements with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaborations with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Institute, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, and Teva Pharmaceutical Industries; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei, Zedira/Dr. Falk Pharma, Exelixi GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, KM Biologics, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics. The company was founded in 1781 and is headquartered in Tokyo, Japan. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Website
Hauptsitz
Tokyo, Japan
Gegründet
1781
Takeda Pharmaceutical Company Ltd is listed in the Healthcare sector of the New York Börse with ticker TAK. The last closing price for Takeda Pharmaceutical was US$15,68. Over the last year, Takeda Pharmaceutical shares have traded in a share price range of US$ 12,99 to US$ 18,895.

Takeda Pharmaceutical currently has 1.579.837.574 shares in issue. The market capitalisation of Takeda Pharmaceutical is US$24,77 billion. Takeda Pharmaceutical has a price to earnings ratio (PE ratio) of 42.21.

TAK Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.382.4836601307215.315.8615.23342105115.6524053DR
4-1.04-6.2200956937816.7216.7614.84321604015.94551334DR
12-2.3-12.791991101217.9818.89514.84310112216.95087609DR
261.319.1162143354214.3718.89514.2300060416.93611025DR
520.463.022339027615.2218.89512.99311442315.65476879DR
156-0.42-2.6086956521716.118.89512.575230185714.91327048DR
260-1.6-9.2592592592617.2818.89512.28239535714.87757097DR

TAK - Frequently Asked Questions (FAQ)

What is the current Takeda Pharmaceutical Company Ltd share price?
The current share price of Takeda Pharmaceutical Company Ltd is US$ 15,68
How many Takeda Pharmaceutical Company Ltd shares are in issue?
Takeda Pharmaceutical Company Ltd has 1.579.837.574 shares in issue
What is the market cap of Takeda Pharmaceutical Company Ltd?
The market capitalisation of Takeda Pharmaceutical Company Ltd is USD 24,77B
What is the 1 year trading range for Takeda Pharmaceutical Company Ltd share price?
Takeda Pharmaceutical Company Ltd has traded in the range of US$ 12,99 to US$ 18,895 during the past year
What is the PE ratio of Takeda Pharmaceutical Company Ltd?
The price to earnings ratio of Takeda Pharmaceutical Company Ltd is 42,21
What is the cash to sales ratio of Takeda Pharmaceutical Company Ltd?
The cash to sales ratio of Takeda Pharmaceutical Company Ltd is 1,77
What is the registered address of Takeda Pharmaceutical Company Ltd?
The registered address for Takeda Pharmaceutical Company Ltd is 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Tokyo, 103-8668
What is the Takeda Pharmaceutical Company Ltd website address?
The website address for Takeda Pharmaceutical Company Ltd is www.takeda.com
Which industry sector does Takeda Pharmaceutical Company Ltd operate in?
Takeda Pharmaceutical Company Ltd operates in the Pharmaceuticals sector

TAK Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen